These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12117457)

  • 1. Fixed low-dose combination therapy for hypertension.
    Waeber B
    Curr Hypertens Rep; 2002 Aug; 4(4):298-306. PubMed ID: 12117457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose combinations versus monotherapies in the treatment of hypertension.
    Waeber B; Brunner HR
    J Hypertens Suppl; 1997 Mar; 15(2):S17-20. PubMed ID: 9218193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for the use of very-low-dose combinations as first-line treatment of hypertension.
    Waeber B; Brunner HR
    J Hypertens Suppl; 2001 Nov; 19(4):S3-8. PubMed ID: 11848261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats.
    Sica DA
    Drugs; 2002; 62(3):443-62. PubMed ID: 11827559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using fixed-dose combination therapies to achieve blood pressure goals.
    Chrysant SG
    Clin Drug Investig; 2008; 28(11):713-34. PubMed ID: 18840014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atenolol/nifedipine combination: efficacy and tolerability of low dose synergistic bitherapy in the treatment of arterial hypertension].
    Krivitzky A; Nguyen G; Gaudouen Y; Legrand M; Cohen R
    Drugs; 1998; 56 Suppl 2():31-43. PubMed ID: 9813740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
    Weisser B; Gerwe M; Braun M; Funken C
    Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
    Waeber B
    J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment strategies in essential arterial hypertension].
    Waeber B
    Rev Prat; 1999 Mar; 49(5):520-5. PubMed ID: 10358402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity-mortality trials?
    Struijker-Boudier HA; Ambrosioni E; Holzgreve H; Laurent S; Mancia G; Ruilope LM; Waeber B
    Int J Clin Pract; 2007 Sep; 61(9):1592-602. PubMed ID: 17686100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multifactorial nature of hypertension: the greatest challenge for its treatment?
    Waeber B; Brunner HR; ;
    J Hypertens Suppl; 2001 Sep; 19(3):S9-16. PubMed ID: 11713851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice.
    Mazza A; Lenti S; Schiavon L; Sacco AP; Dell'Avvocata F; Rigatelli G; Ramazzina E
    Adv Ther; 2017 Apr; 34(4):975-985. PubMed ID: 28299716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy.
    Basile J; Neutel J
    Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):119-27. PubMed ID: 20042448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
    Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
    Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial.
    Webster R; Salam A; de Silva HA; Selak V; Stepien S; Rajapakse S; Amarasekara S; Amarasena N; Billot L; de Silva AP; Fernando M; Guggilla R; Jan S; Jayawardena J; Maulik PK; Mendis S; Mendis S; Munasinghe J; Naik N; Prabhakaran D; Ranasinghe G; Thom S; Tisserra N; Senaratne V; Wijekoon S; Wijeyasingam S; Rodgers A; Patel A;
    JAMA; 2018 Aug; 320(6):566-579. PubMed ID: 30120478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amlodipine/benazepril: fixed dose combination therapy for hypertension.
    Faulkner MA; Hilleman DE
    Expert Opin Pharmacother; 2001 Jan; 2(1):165-78. PubMed ID: 11336577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.